skip to main content

GLP-1 receptor agonist counselling — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModeratePatient Counselling and Pharmaceutical CareGLP-1 receptor agonist counsellingGPhC CRA

A patient starting weekly semaglutide for type 2 diabetes asks what adverse effects to expect and when to seek help. She also takes metformin. What would you advise the patient?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Nausea is common, but severe abdominal pain needs urgent advice

GLP-1 receptor agonists commonly cause gastrointestinal adverse effects, especially during dose escalation. Severe persistent abdominal pain may suggest pancreatitis and requires urgent assessment. Semaglutide dosing is weekly for relevant preparations, not daily. Storage requirements depend on the product and whether it is in use.

Reference: BNF; NICE CKS